Valuation: Innova Captab Limited

Market Cap 58.43B 622M 558M 510M 465M 876M 904M 6.14B 2.45B 31.18B 2.33B 2.28B 98.43B P/E 2027 *
30.4x
P/E 2028 * 22.5x
Enterprise Value 58.43B 622M 558M 510M 465M 876M 904M 6.14B 2.45B 31.18B 2.33B 2.28B 98.43B EV / Sales 2027 *
2.83x
EV / Sales 2028 * 2.36x
Free-Float
31.57%
Yield 2027 *
-
Yield 2028 * -
1 day-1.50%
1 week-2.85%
Current month-0.41%
1 month-10.85%
3 months+8.05%
6 months+17.23%
Current year+41.80%
1 week 962.2
Extreme 962.2
1,064.4
1 month 952
Extreme 952
1,188
Current year 622
Extreme 622
1,353.5
1 year 622
Extreme 622
1,353.5
3 years 421.35
Extreme 421.35
1,353.5
5 years 421.35
Extreme 421.35
1,353.5
10 years 421.35
Extreme 421.35
1,353.5
Manager TitleAgeSince
Chief Executive Officer 50 2022-03-17
Director of Finance/CFO - 2024-03-29
Chief Tech/Sci/R&D Officer - 2021-02-11
Director TitleAgeSince
Director/Board Member 50 2022-03-17
Chairman 54 2022-03-17
Director/Board Member - 2020-02-27
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%-2.85%+23.56% - 628M
+0.54%-4.04%+45.10%+128.54% 1,216B
+1.23%+0.59%+46.98%+81.16% 656B
+0.95%-1.55%+32.55%+105.62% 509B
-0.36%-3.25%+47.17%+64.58% 384B
-0.10%-1.96%+70.89%+40.49% 362B
-0.78%-0.52%+30.57%+57.98% 311B
-0.80%-0.21%+8.54%+35.56% 293B
+0.11%-1.03%+46.14%+69.05% 249B
-0.38%-1.89%+35.70%+106.37% 208B
Average -0.24%+0.40%+38.72%+76.59% 418.84B
Weighted average by Cap. +0.10%+0.03%+42.24%+88.47%

Financials

2027 *2028 *
Net sales 20.62B 219M 197M 180M 164M 309M 319M 2.17B 864M 11B 823M 806M 34.74B 24.81B 264M 237M 216M 197M 372M 384M 2.61B 1.04B 13.24B 990M 969M 41.78B
Net income 1.92B 20.47M 18.36M 16.78M 15.31M 28.85M 29.76M 202M 80.64M 1.03B 76.83M 75.18M 3.24B 2.59B 27.6M 24.75M 22.62M 20.65M 38.9M 40.13M 273M 109M 1.38B 104M 101M 4.37B
Net Debt - -
Projected Income Statement - Annual - Innova Captab Limited
Logo Innova Captab Limited
Innova Captab Limited is an India-based integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes Contract Development and Manufacturing (CDMO) Services and Products, Domestic Branded Generics, and International Branded Generics. Its CDMO business provides research, product development and manufacturing services. Its Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including tablets, capsules, dry syrups, and others.
Employees
1,600
Date Price Change Volume
26-11-06 ₹1,021.10 -1.50% 18,865
26-11-05 ₹1,036.60 +0.15% 48,059
26-11-04 ₹1,035.00 +3.16% 62,436
26-11-03 ₹1,003.30 +0.21% 23,761
26-11-02 ₹1,001.20 -2.35% 22,897
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Innova Captab Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,021.10INR
Average target price
1,116.00INR
Spread / Average Target
+9.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Innova Captab Limited
  1. Stock Market
  2. Stocks
  3. INNOVACAP Stock